Moving Toward Personalized Medicine in Gynecologic Cancers
Int J Radiat Oncol Biol Phys
.
2024 May 1;119(1):1-5.
doi: 10.1016/j.ijrobp.2023.11.025.
Authors
Michelle Ludwig
1
,
Neil Taunk
2
,
Junzo Chino
3
,
Lara Hathout
4
,
Eric Leung
5
,
Emma Fields
6
Affiliations
1
Department of Radiation Oncology, Baylor College of Medicine, Houston, Texas.
2
Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
3
Department of Radiation Oncology, Duke Cancer Center, Durham, North Carolina.
4
Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
5
Department of Radiation Oncology, Odette Cancer Centre-Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
6
Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia. Electronic address: emma.fields@vcuhealth.org.
PMID:
38631739
DOI:
10.1016/j.ijrobp.2023.11.025
No abstract available
Publication types
Editorial
MeSH terms
Biomarkers, Tumor
Female
Genital Neoplasms, Female*
Humans
Precision Medicine*
Substances
Biomarkers, Tumor